Biogen BIIB
NASDAQ BIIB
$253.84 +12.86 (+5.34%)
At close: Oct 22, 2026 · 4:00 PM EDT

Biogen (BIIB) Free Cash Flow (2009 - 2026)

Updated

Biogen (BIIB) recorded Free Cash Flow of $408 million in Q2 2026, up 203.8% from $134.3 million a year earlier but down 31.3% from the prior quarter.

Analysis

Biogen (BIIB) Free Cash Flow (2009 - 2026) Analysis & Trends

On a TTM basis, Biogen's Free Cash Flow came in at $2.7 billion as of Jun 30, 2026, up 36.3% year-over-year; for FY2025, it came in at $2.05 billion, down 24.7% from FY2024.

  • Annual Free Cash Flow has a five-year compound annual growth rate of -11.6% (FY2020 to FY2025).
  • Across earlier years, Free Cash Flow came in at $2.72 billion in FY2024 (+114.3%), $1.27 billion in FY2023 (+11.0%), $1.14 billion in FY2022 (-66.2%) and $3.38 billion in FY2021 (-11.1%).
  • Quarterly Free Cash Flow has ranged from -$261.4 million in Q4 2022 to $1.23 billion in Q3 2025 over the past five years.
  • On a year-over-year basis, Free Cash Flow rose in four of the last seven quarters, with growth averaging 44.6%.
  • Peak year-over-year performance for Free Cash Flow in the last five years was growth of 274.1% in Q1 2023, against a decline of 84.6% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $594.3 million (Q1 2026), $468 million (Q4 2025) and $1.23 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 6.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.11 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.01 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.43 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 302.00 Mn
10 Biogen 37.52 Bn 24.18 Bn 1.96 Bn 408.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 408.00 Mn
Mar 31, 2026 594.30 Mn
Dec 31, 2025 468.00 Mn
Sep 30, 2025 1.23 Bn
Jun 30, 2025 134.30 Mn
Mar 31, 2025 222.20 Mn
Dec 31, 2024 721.60 Mn
Sep 30, 2024 900.60 Mn
Jun 30, 2024 592.30 Mn
Mar 31, 2024 507.30 Mn
Dec 31, 2023 -52.70 Mn
Sep 30, 2023 518.20 Mn
Jun 30, 2023 416.00 Mn
Mar 31, 2023 388.70 Mn
Dec 31, 2022 -261.40 Mn
Sep 30, 2022 601.90 Mn
Jun 30, 2022 699.60 Mn
Mar 31, 2022 103.90 Mn
Dec 31, 2021 786.70 Mn
Sep 30, 2021 763.30 Mn
API Access

Biogen Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=BIIB&period=max&api_key=YOUR_API_KEY